Market Access -

in News
Jailed pharma exec fined £47m and banned from industry
January 17, 2022 Share
X
Jailed pharma exec fined £47m and banned from industry
https://pharmaphorum.com/news/jailed-pharma-exec-fined-47m-banned-industry/
in News
Senate panel backs Biden’s FDA selection Robert Califf
January 14, 2022 Share
X
Senate panel backs Biden’s FDA selection Robert Califf
https://pharmaphorum.com/news/senate-panel-backs-bidens-fda-commissioner-selection-califf/

Latest News

Third dose of AZ’s COVID jab boosts Omicron antibodies

Preliminary data from an ongoing trial of AstraZeneca’s COVID-19 vaccine Vaxzevria has shown that a booster dose stimulates

Third dose of AZ’s COVID jab boosts Omicron antibodies

https://pharmaphorum.com/news/third-dose-of-azs-covid-jab-boosts-omicron-antibodies/

Dream result for Idorsia as FDA clears its insomnia drug

Swiss biotech Idorsia has claimed FDA approval for its first product – insomnia treatment Quviviq – setting up

Dream result for Idorsia as FDA clears its insomnia drug

https://pharmaphorum.com/news/dream-result-for-idorsia-as-fda-clears-its-insomnia-drug/

After a Scottish aye, NICE says no to Lynparza for prostate cancer

AstraZeneca’s PARP inhibitor Lynparza should not be made available routinely on the NHS n England and Wales as

After a Scottish aye, NICE says no to Lynparza for prostate cancer

https://pharmaphorum.com/news/after-a-scottish-aye-nice-says-no-to-lynparza-for-prostate-cancer/

See all

Views & analysis

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

Access to medicines is “one of the most challenging policy areas in every country in the European region”

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

https://pharmaphorum.com/views-analysis-market-access/oslo-medicines-initiative-balance-innovation-incentivisation-with-security-of-access/

Nine for 2022: innovation and opportunities in healthcare

In the second part of our examination of issues that will shape the course of 2022, we’ll update

Nine for 2022: innovation and opportunities in healthcare

https://pharmaphorum.com/digital/2022-innovation-opportunities-healthcare-digital/

Nine for 2022: International issues that are compelling, new or changed in 2022

The year 2020 ended on a note of hope, with the 8th December vaccination of 91-year-old Margaret Keenan,

Nine for 2022: International issues that are compelling, new or changed in 2022

https://pharmaphorum.com/r-d/international-issues-compelling-new-changed-2022/

See all

Debates & Insights

Innovative contracting in Europe – a Trojan horse?

Overview With pricing of drugs at the centre of political and social debate, the market access and pricing

Innovative contracting in Europe – a Trojan horse?

https://pharmaphorum.com/market-access-2/innovative-contracting-in-europe-a-trojan-horse/

Launch excellence in a disrupted world – challenges & opportunities

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care

Launch excellence in a disrupted world – challenges & opportunities

https://pharmaphorum.com/market-access-2/launch-excellence-in-a-disrupted-world-challenges-opportunities/

Orphan medicines launch excellence: sustaining launch success

Overview Launching orphan medicines excellently will become even more important over the next five years as more patients

Orphan medicines launch excellence: sustaining launch success

https://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/

See all

Partner Content

SMi’s 5th Annual 3D Cell Culture Virtual Conference

3D Cell Culture

SMi’s 5th Annual 3D Cell Culture Virtual Conference

https://pharmaphorum.com/events/smis-5th-annual-3d-cell-culture-virtual-conference/

Patient and market insights from leading KOLs and life science leaders

Insights from leading KOLs in new Dermatology eBook

Patient and market insights from leading KOLs and life science leaders

https://pharmaphorum.com/partner-content/patient-and-market-insights-from-leading-kols-and-life-science-leaders/

Is there a faster way to build clinical trials?

Easier and faster Clinical Trials with Clinical MDR.

Is there a faster way to build clinical trials?

https://pharmaphorum.com/partner-content/is-there-a-faster-way-to-build-clinical-trials/

See all

Search

Advanced Search

Trending